Keywords
Hemophagocytic lymphohistiocytosis, Histiocyte, HLH-2004
Abstract
Hemophagocytic lymphohistiocytosis (HLH) is a syndrome characterized by inappropriately activated lymphocytesand natural killer cells that produce high concentrations of cytokines. It is evidenced that "hypercytokinemia"and subsequently uncontrolled activation of histiocytes/ macrophages and T-lymphocytes underline the progressiveorgan dysfunction which leads to death in affected patients. The predominant clinical findings of HLH are persistentfever, cytopenias, hepato-splenomegaly and hemophagocytosis. Diagnosing HLH is extremely challenging and HLH isusually fatal if untreated. The Histiocyte Society treatment study (HLH-2004) outlines diagnostic criteria and treatmentprotocol, based on chemo-immunotherapy, as well as treatment of underlying conditions and supportive care. Subsequenthematopoietic stem cell transplantation is recommended for patients with familial disease or molecular diagnosis,and patients with severe and persistent, or reactivated disease.
Key words: Hemophagocytic lymphohistiocytosis, Histiocyte, HLH-2004
Recommended Citation
Surapolchai, Pacharapan.
2010
Hemophagocytic lymphohistiocytosis.
Asian Medical Journal and Alternative Medicine. 10,
2 (Apr. 2010 ), 201-211.
Available at: https://doi.org/10.70933/2773-9465.1376
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-No Derivative Works 4.0 International License.
